Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
17.06
+0.21 (1.25%)
Feb 3, 2026, 1:24 PM CST
Shandong Buchang Pharmaceuticals Company Description
Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China.
It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes.
The company was founded in 1993 and is based in Heze, China.
Shandong Buchang Pharmaceuticals Co., Ltd.
| Country | China |
| Founded | 1993 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 7,689 |
| CEO | Chao Zhao |
Contact Details
Address: No. 369 Zhonghua West Road Heze, 274000 China | |
| Phone | 86 40 0678 9828 |
| Website | buchang.com |
Stock Details
| Ticker Symbol | 603858 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002FV6 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Chao Zhao | President and Director |
| Yi Min Wang | Executive Vice President and Vice Chairman |
| Ren Hui Xue | Vice President of Marketing and Director |
| Xin Wang | Director and Secretary |
| Bao Cai Wang | Vice President |
| Dr. Zhao Buchang M.D. | Founder |
| Xiaogang Zhao | Chief Financial Officer |
| Kai Cheng | Accounting Supervisor |
| Wei Jun Li | Vice President of Administration and Human Resources |
| Haiqin Wu | Chairman of the Academic Committee |